Immunological memory by T cells is a fundamental characteristic of the adaptive immune system. The underlying principle is that exposure to a pathogen leads to the generation of long-lived memory T cells, which provide an immediate and stronger immune response following re-encounter of the same pathogen, ensuring effective protection following a pathogen reinfection or vaccination (1). While pathogenic eradication and thus re-establishment of quiescence has been assumed to be a prerequisite for the formation of immunological memory, recent advances in the field have revealed that T cells with memory-like characteristics can be found among exhausted T cell responses in ongoing infections or in tumors (2). As such, these cells, distinguishable by the expression of the transcription factor T-cell factor 1 (TCF1) or the chemokine receptor CXCR5, retain proliferative potential and the ability to self-renew while also continuously replenishing the pool of antigen-specific exhausted effector T cells, thereby mediating viral or tumor control (3, 4). Interestingly, TCF1+ memory-like or precursor T cells can also exhibit features of T cell exhaustion, as described for many actively-persisting viral infections such as Human Immunodeficiency Virus (HIV) (5, 6) and Hepatitis B or C viruses in humans (7, 8), Lymphocytic choriomeningitis virus (LCMV) infections in mice (3–5, 9), and in tumor settings both in humans and mice (10–13). Most importantly, TCF1+ T cells are responsible for the boost of immunity following immune checkpoint blockade in immunotherapy (3, 4). Thus, promoting our understanding of the molecular characteristics of these memory-like or precursor T cells will drive the design and development of novel immunotherapies to modulate exhausted T cell responses in chronic infections and tumors.
This Research Topic was developed to encourage high-quality scientific outputs on this particular theme. As such, the Research Topic comprehensively highlights in two review articles as well as three primary research articles the importance of memory-like or precursor T cells in chronic infections and tumors. First, Martinez-Usatorre et al. unequivocally identified and established an improved cell sorting protocol to isolate TCF1+ precursor T cells from solid tumors. The authors performed transcriptomic analysis of PD1+ T cells derived from murine B16 tumors as well as primary human melanoma tumors to identify an enriched expression of Slamf6 by concomitant lack of Entpd1 (encodes CD39) and Havcr2 (encodes TIM3) expression among precursor T cells. Based on these expression patterns, they demonstrate that PD1+Slamf6+CD39-TIM3- tumor-infiltrating lymphocytes (TILs) displayed higher proliferative potential when isolated, transferred, and rechallenged, compared to the PD1+Slamf6-CD39+TIM3+ counterpart. Thus, Martinez-Usatorre et al. nicely demonstrate a viable approach to improve the isolation of superior TILs that can strongly advance efficacy of adoptive cell therapy.
Zhang et al. addressed the role of the inhibitory receptor CD160 on CD8 T cells responding to chronic viral infection. The authors first demonstrate that CD160 expression positively correlates with improved clinical signs such as enhanced CD4 T cell counts and reduced viral burden in people with HIV. Moreover, the authors utilize the preclinical chronic LCMV model to elegantly demonstrate that CD160 is required to maintain prolonged viral control. Importantly, the authors reveal that the lack of viral control is due to an impaired generation of TCF1+ precursor T cells in the absence of CD160 and thus an impairment in sustaining a long-term T cell response. Thus, signaling through CD160 is essential for the formation of TCF1+ precursor T cells in response to chronic viral infection.
Kumashie et al. set up a mouse model to study T cells responding to persistent antigen presented by hepatocytes. By doing so, the authors identify exhausted intrahepatic precursor T cells and demonstrate that these cells retain proliferate and self-renewal potential similar to splenic precursor T cells responding to chronic viral infections. Interestingly, the authors demonstrate for the first time that precursor T cells retain improved metabolic and mitochondrial potential compared to their CXCR5- counterpart. This is an important observation that addresses a central topic of how T cell exhaustion and T cell metabolism are regulated and connected. Li and Zhang dive into this field by reviewing the current literature of cellular metabolism of different memory T cell subsets and highlighting different possibilities to target mitochondrial metabolism to boost T cell memory formation and metabolic fitness to improve cancer immunotherapy.
Finally, the review by Nüssing et al. takes a step back and addresses specific similarities and discrepancies of T cell exhaustion and tolerance. The authors discuss how tumors can manipulate tolerance mechanisms to evade immune recognition.
Overall, this Research Topic contains a range of articles that highlight the critical role of memory-like or precursor T cells across a wide range of diseases emphasizing the importance to further improve our understanding of memory T cell biology to design new or improve the efficacy of current immunotherapies.
Statements
Author contributions
All authors contributed equally in writing the manuscript.
Funding
LN is funded by the Emerson Collective and Cancer Research UK (Biotherapeutics Drug Discovery Project Award A29991).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
WilliamsMABevanMJ. Effector and memory CTL differentiation. Annu Rev Immunol. (2007) 25:171–92. 10.1146/annurev.immunol.25.022106.141548
2.
KalliesAZehnDUtzschneiderDT. Precursor exhausted T cells: key to successful immunotherapy?Nat Rev Immunol. (2020) 20:128–36. 10.1038/s41577-019-0223-7
3.
UtzschneiderDTCharmoyMChennupatiVPousseLFerreiraDPCalderon-CopeteSet al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity. (2016) 45:415–27. 10.1016/j.immuni.2016.07.021
4.
ImSJHashimotoMGernerMYLeeJKissickHTBurgerMCet al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature. (2016) 537:417–21. 10.1038/nature19330
5.
LeongYAChenYOngHSWuDManKDeleageCet al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. (2016) 17:1187–96. 10.1038/ni.3543
6.
SekineTPerez-PottiANguyenSGorinJBWuVHGostickEet al. TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells. Sci Immunol. (2020) 5: eaba7918. 10.1126/sciimmunol.aba7918
7.
WielandDKemmingJSchuchAEmmerichFKnollePNeumann-HaefelinCet al. TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation. Nat Commun. (2017) 8:15050. 10.1038/ncomms15050
8.
HenselNGuZSagarWielandDJechowKKemmingJet al. Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection. Nat Immunol. (2021) 22:229–39. 10.1038/s41590-020-00817-w
9.
UtzschneiderDTGabrielSSChisangaDGlouryRGubserPMVasanthakumarAet al. Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat Immunol. (2020) 21:1256–66. 10.1038/s41590-020-0760-z
10.
MillerBCSenDRAlAbosy RBiKVirkudYVLaFleurMWet al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. (2019) 20:326–36. 10.1038/s41590-019-0312-6
11.
SiddiquiISchaeubleKChennupatiVFuertesMarraco SACalderon-CopeteSPaisFerreira Det al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity. (2019) 50:195–211.e10. 10.1016/j.immuni.2018.12.021
12.
JansenCSProkhnevskaNMasterVASandaMGCarlisleJWBilenMAet al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature. (2019) 576:465–70. 10.1038/s41586-019-1836-5
13.
BrummelmanJMazzaEMCAlvisiGColomboFSGrilliAMikulakJet al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J Exp Med. (2018) 215:2520–35. 10.1084/jem.20180684
Summary
Keywords
exhaustion, memory T cells, chronic infection, tumor, PD-1
Citation
Hofmann M, Jandus C, Lee LN and Utzschneider DT (2021) Editorial: Memory T Cells in Chronic Infections and Tumors. Front. Immunol. 12:656010. doi: 10.3389/fimmu.2021.656010
Received
19 January 2021
Accepted
01 February 2021
Published
17 February 2021
Volume
12 - 2021
Edited and reviewed by
Scott N. Mueller, The University of Melbourne, Australia
Updates
Copyright
© 2021 Hofmann, Jandus, Lee and Utzschneider.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Daniel T. Utzschneider daniel.utzschneider@unimelb.edu.au
This article was submitted to Immunological Memory, a section of the journal Frontiers in Immunology
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.